Skip to main content

MARSHALL WACE, LLP

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1318757 LONDON, X0

Position in BCRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,527,640
+$181,180 QoQ
Shares Held
252,764
+2.6% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 316 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. BCRX ranks #17 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BCRX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,527,640 252,764
2026-03-31 $2,346,460 246,477
2025-09-30 $5,551,408 731,411
2025-06-30 $1,284,074 143,312
2024-09-30 $252,753 33,257
2023-09-30 $951,282 134,362
2023-03-31 $1,056,669 126,699
2022-06-30 $376,372 35,574
2022-03-31 $17,655,855 1,085,846
2021-03-31 $1,860,143 182,905
2020-06-30 $239,318 50,277
2020-03-31 $143,320 71,660